Literature DB >> 1521738

Function of the c-Myc oncoprotein.

G J Kato1, C V Dang.   

Abstract

The c-Myc protein, the product of the c-myc proto-oncogene, is a nuclear phosphoprotein with DNA binding properties. Deregulated c-myc expression participates in the development of experimentally induced tumors, and its expression appears to be abnormal in many naturally occurring malignancies. Although the precise molecular mechanism of c-Myc activity in oncogenesis and in normal cell proliferation is unknown, recent advances have uncovered a series of molecular and cellular properties of c-Myc. These properties include nuclear localization, transcriptional activation, oligomerization nonspecific and specific DNA binding. Recently, the c-Myc protein was found to heterodimerize with Max, a protein that cooperates with c-Myc to bind specifically to a core DNA sequence, CAC(G/A)TG. These characteristics suggest that c-Myc participates in the regulation of gene transcription in normal and neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521738     DOI: 10.1096/fasebj.6.12.1521738

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  31 in total

1.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 2.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 3.  Modulation of transcription factor function by O-GlcNAc modification.

Authors:  Sabire Ozcan; Sreenath S Andrali; Jamie E L Cantrell
Journal:  Biochim Biophys Acta       Date:  2010-03-02

4.  Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene.

Authors:  E M Klenova; R H Nicolas; S U; A F Carne; R E Lee; V V Lobanenkov; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

5.  Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.

Authors:  Su Cheol Park; Changjun Zeng; Benjamin Tschudy-Seney; Ngoc Tue Nguyen; Jong Ryeol Eun; Yanling Zhang; Rajendra Ramsamooj; Yanghong Zhang; Min Zhao; Neil D Theise; Huaijun Zhou; Mark A Zern; Yuyou Duan
Journal:  Stem Cells Dev       Date:  2015-05-12       Impact factor: 3.272

6.  Differentiation by magnesium ions of affinities of nuclear proteins for consensus core nucleotide element of the transcription factor c-Myc in murine brain.

Authors:  K Ogita; T Amizuka; Y Azuma; Y Yoneda
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

7.  Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Authors:  Efren Riu; Tura Ferre; Alex Mas; Antonio Hidalgo; Sylvie Franckhauser; Fatima Bosch
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 8.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

9.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.